Abstract
Triflavin, an Arg-Gly-Asp (RGD)-containing snake venom peptide, inhibits B16-F10 mouse melanoma cell adhesion to extracellular matrices, e.g., fibronectin, vitronectin, fibrinogen, and collagen type I. In this study, GRGDS inhibits B16-F10 mouse melanoma cell adhesion to immobilized triflavin in a dose-dependent manner. In addition, flow-cytometric analysis and the fluorescence staining method in which FITC-triflavin is utilized as a binding ligand were used. GRGDS inhibits the binding of FITC-triflavin to B16-F10 cells. Additionally, the above results suggest that triflavin directly binds to its receptors expressed on B16-F10 cell surface primarily via its RGD sequence, thereby inhibiting B16-F10 cell adhesion to extracellular matrices.
Original language | English |
---|---|
Pages (from-to) | 359-364 |
Number of pages | 6 |
Journal | Journal of Biomedical Science |
Volume | 3 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1996 |
Keywords
- Extracellulr matrix
- Melanoma cells
- RGD-containing peptide
- Triflavin
ASJC Scopus subject areas
- Biochemistry, medical
- Pharmacology (medical)
- Molecular Biology
- Clinical Biochemistry
- Endocrinology, Diabetes and Metabolism
- Cell Biology